Paolo Cappella

Quantitative assessment of the complex dynamics of G1, S, and G2-M checkpoint activities.

Paolo Ubezio, Monica Lupi, Valentina Colombo, 2009, Cancer research.

1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.

Paola Storici, Maurizio Rocchetti, Enrico Pesenti, 2006, Journal of medicinal chemistry.

Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase.

Antonella Isacchi, Riccardo Colombo, Enrico Pesenti, 2010, Cancer research.

Simulating cancer-cell kinetics after drug treatment: Application to cisplatin on ovarian carcinoma

Paolo Ubezio, Francesco Montalenti, Paolo Cappella, 1998 .

Highly Multiplexed Phenotypic Imaging for Cell Proliferation Studies

Paolo Cappella, F. Gasparri, P. Cappella, 2014, Journal of biomolecular screening.

Multiparametric Cell Cycle Analysis by Automated Microscopy

Paolo Cappella, F. Gasparri, A. Galvani, 2006, Journal of biomolecular screening.

From “Click” to “Fenton” chemistry for 5‐bromo‐2′‐deoxyuridine determination

Paolo Cappella, F. Gasparri, P. Cappella, 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer

Paola Storici, Cristina Alli, Maurizio Rocchetti, 2007, Molecular Cancer Therapeutics.

Interpreting cell cycle effects of drugs: the case of melphalan

Paolo Ubezio, Monica Lupi, Paolo Cappella, 2006, Cancer Chemotherapy and Pharmacology.